EVT-101, also known as ENS-101, is an experimental medication which originated from Roche and is under development by Evotec AG for the treatment of major depressive disorder. It acts as a selective NMDA receptor subunit 2B (NR2B) antagonist.
Molecular Weight:
318.3
CAS Number:
[627525-33-1]
Formula:
C16H13F3N4
Target:
Others
T68973
* VAT and and shipping costs not included. Errors and price changes excepted
